AJPB® Translating Evidence-Based Research Into Value-Based Decisions®
January/February 2018
Volume: 10
Issue: 1
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Approves First Once-Monthly Subcutaneous Olanzapine LAI for Adults With Schizophrenia
2
Pneumonic Plague: What Pharmacists Need to Know About Treatment
3
Rising Gallbladder Complications With GLP-1 Receptor Agonists Call for Closer Pharmacist Monitoring
4
FDA Approves Pritelivir for Refractory HSV Lesions in Immunocompromised Adults
5